Breaking News For J&J Covid Vaccine Takers In San Francisco

Breaking News For J&J Covid Vaccine Takers In San Francisco
SHARE

It’s been just revealed something extremely important about people who got the Johnson & Johnson shots in San Francisco. USA Today began their new article by saying that “Last week, Julia Ma did something the majority of people in the United States can’t – she got an authorized second COVID-19 booster shot after one dose of Johnson & Johnson’s vaccine.”

They also noted that only J&J recipients who are immunocompromised are authorized by the federal government to get a single initial shot and two boosters.

It’s also important to note the fact that this month the San Francisco Department of Public Health sanctioned a second booster dose for everyone who got J&J as their first shot.

Source: Pixabay
Source: Pixabay

This move makes it the only known place in America where a third shot is officially allowed for those with normal immune protection.

The person mentioned in the publication above noted that she is hoping to travel next month and wanted to make sure she wouldn’t be a vector for others while omicron surged.

“I don’t want my vax status to be a barrier to that,” she said.

She continued and said this:

“I opted for the J&J initially because I liked that it was only one shot, but I sometimes feel like the CDC guidelines forget about J&J recipients.”

We suggest that you check out the complete article mentioned above and learn all the available details. 

Pfizer CEO reveals what can control covid 19 from now on

Not too long ago, we revealed that the pandemic seems to be getting closer and closer to its end with the lighter variant called Omicron. Although this variant of the virus is more contagious, as you probably know by now, it has lighter symptomatology for most people. Anyway, the pandemic is expected to become endemic soon. 

It’s been just revealed that an extremely important pharmaceutical executive is saying that pandemic-related restrictions could be relaxed.

Dr. Scott Gottlieb is a former director of the Food and Drug Administration (FDA) and current board member at Pfizer. 

“I think certainly on the East Coast, where you see cases declining dramatically, we need to be willing to lean in and do that very soon I think as conditions improve we have to be willing to relax some of these measures with the same speed that we put them in place.”

Stay tuned for more exciting news, and also make sure to remain safe. 


SHARE
Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.